Research: A Citation Profile Of David Baltimore, Rockefeller University's New President

The institution that David Baltimore will guide in the coming years has a well-earned reputation as one of the world's best biomedical research establishments. But is Rockefeller University still riding high, or is it resting on its laurels? According to data from the Science Citation Index (SCI) of the Philadelphia-based Institute for Scientific Information (ISI), Rockefeller University is not only maintaining its dominant position, but also moving ahead. The accompanying chart illustrates

Written byDavid Pendlebury
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The institution that David Baltimore will guide in the coming years has a well-earned reputation as one of the world's best biomedical research establishments. But is Rockefeller University still riding high, or is it resting on its laurels? According to data from the Science Citation Index (SCI) of the Philadelphia-based Institute for Scientific Information (ISI), Rockefeller University is not only maintaining its dominant position, but also moving ahead. The accompanying chart illustrates the average citations per paper from Rockefeller University relative to the average for all science papers produced in the United States (which represents a baseline to control for changes in the size of the database over the years). The period surveyed, 1973-88, is divided into a dozen overlapping five-year intervals, each of which includes papers published in those five years and citations to those papers during the same five years. Although slipping slightly in the early 1980s, Rockefeller ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies